Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY · Published 2026-07-27 · DOI 10.1007/s00210-026-05645-7

Authors (6)

Mingyuan Wu, Fenggang Hou, Zhaoshuo Yang, Zhenfeng Zhu, Yao Wang, Hong Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wu, M., Hou, F., Yang, Z., et al. (2026). Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. https://doi.org/10.1007/s00210-026-05645-7

Related articles